claim: low risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine
evidence_1: a nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness.", "superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.", "being protected against influenza, tiv recipients may lack temporary non-specific immunity that protected against other respiratory viruses."
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  )